BioStrategies and its key investigators have been leaders for over two decades in Research and Development as well as manufacturing systems of novel plant-based health products. BioStrategies R&D focuses on several classes of human and animal proteins important for treatment of infection diseases and rare orphan diseases, among others.

Our company product portfolio is backed by proprietary IP including several patents, approved or pending.


Radin, D.N., C.L. Cramer, K.k Oishi, D.L Weissenborn.  Production of lysosomal enzymes in plant-based expression systems (joint patent, Virginia Tech/CropTech), US Patent No. 5,929,304 issued 1999; European Patent No. 0865499 issued 2009.

Cramer, C.L, Dolan, M., Medrano G., Radin, D.N., Plant-based expression of avian interleukin-12 and methods of producing same, US Patent No. 8,431,774, Issued 04/30/2013.

Cramer, C.L., M.J. Reidy, M.C. Dolan. Methods of delivery of molecules to cells using ricin subunit and compositions relating to same (AR State University), PCT/US2008/066790; Priority date: 6/15/2007; US Appl. No. 12/664,342 filed Dec. 2009; European Patent Appl. No. 08770903.6 patent pending.

Radin, D.N. Plant lectins as Carriers of Associated Substances into Animal and Human Cells, US Patent Application Number 13/906/203, 05/30/2013.